Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Carnitine palmitoyltransferase 1 (CPT1) is a mitochondrial enzyme critical for the metabolism of long-chain fatty acids. It catalyzes the transfer of an acyl group from long-chain fatty acyl-CoA to L-carnitine, forming acylcarnitines. This reaction is essential for transporting fatty acids from the cytosol into mitochondria, where they undergo β-oxidation to produce energy. There are three known isoforms: CPT1A (liver), CPT1B (muscle), and CPT1C (brain). CPT1 activity is rate-limiting in mitochondrial fatty acid oxidation and is tightly regulated by malonyl-CoA.
Malonyl-CoA inhibits CPT1 activity
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Carnitine palmitoyltransferase 1 (CPT1).